Localised Morphea Treated Empirically with Ceftriaxone

Localised morphea is an autoimmune sclerosing disorder of unknown aetiology. Various triggering factors are known to be associated with the disease including infections, vaccination, autoimmune disorders, and trauma. Amongst the infections, the common causative organisms associated with morphea are...

Full description

Bibliographic Details
Main Authors: Deena Patil, Madivalara Yallappa Suparna, Shruthi Madhavi Govindarajulu, Tharayil Kunneth Sumathy
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2023-02-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/17549/60892_CE[Ra1]_F[SK]_PF1(PS_KM_OM)_PN(OM).pdf
_version_ 1797870171953561600
author Deena Patil
Madivalara Yallappa Suparna
Shruthi Madhavi Govindarajulu
Tharayil Kunneth Sumathy
author_facet Deena Patil
Madivalara Yallappa Suparna
Shruthi Madhavi Govindarajulu
Tharayil Kunneth Sumathy
author_sort Deena Patil
collection DOAJ
description Localised morphea is an autoimmune sclerosing disorder of unknown aetiology. Various triggering factors are known to be associated with the disease including infections, vaccination, autoimmune disorders, and trauma. Amongst the infections, the common causative organisms associated with morphea are Borrelia burgdorferi, varicella, and Epstein-Barr virus (EBV). Localised morphea presents as an initial inflammatory stage and a late inactive stage. It is characterised by sclerosis of skin with hyper or depigmentation. The antibiotics effective against borrelia infection are benzyl penicillin, doxycycline, and ceftriaxone. These antibiotics are tried in the treatment of localised morphea. Ceftriaxone is one of the best antibiotics preferred to treat borrelia infection at all stages. Apart from its antibiotic properties, it also has an anti-inflammatory and collagen remodelling properties. All five cases of localised morphea reported here were biopsy proven, Antinuclear Antibody (ANA) and Rheumatoid Arthritis (RA) factor negative. All the cases were treated with weekly single intramuscular dose of ceftriaxone 250 mg. After eight weeks there was remarkable improvement in the induration and pigmentation of the lesions.
first_indexed 2024-04-10T00:24:12Z
format Article
id doaj.art-5cf01059c4e945149d7cd2a0f0350007
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-04-10T00:24:12Z
publishDate 2023-02-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-5cf01059c4e945149d7cd2a0f03500072023-03-15T11:53:13ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2023-02-01172WR01WR0310.7860/JCDR/2023/60892.17549Localised Morphea Treated Empirically with CeftriaxoneDeena Patil0Madivalara Yallappa Suparna1Shruthi Madhavi Govindarajulu2Tharayil Kunneth Sumathy3Assistant Professor, Department of Dermatology, MS Ramaiah Medical College, Bengaluru, Karnataka, India.Assistant Professor, Department of Dermatology, MS Ramaiah Medical College, Bengaluru, Karnataka, India.Senior Resident, Department of Dermatology, MS Ramaiah Medical College, Bengaluru, Karnataka, India.Professor and Head, Department of Dermatology, MS Ramaiah Medical College, Bengaluru, Karnataka, India.Localised morphea is an autoimmune sclerosing disorder of unknown aetiology. Various triggering factors are known to be associated with the disease including infections, vaccination, autoimmune disorders, and trauma. Amongst the infections, the common causative organisms associated with morphea are Borrelia burgdorferi, varicella, and Epstein-Barr virus (EBV). Localised morphea presents as an initial inflammatory stage and a late inactive stage. It is characterised by sclerosis of skin with hyper or depigmentation. The antibiotics effective against borrelia infection are benzyl penicillin, doxycycline, and ceftriaxone. These antibiotics are tried in the treatment of localised morphea. Ceftriaxone is one of the best antibiotics preferred to treat borrelia infection at all stages. Apart from its antibiotic properties, it also has an anti-inflammatory and collagen remodelling properties. All five cases of localised morphea reported here were biopsy proven, Antinuclear Antibody (ANA) and Rheumatoid Arthritis (RA) factor negative. All the cases were treated with weekly single intramuscular dose of ceftriaxone 250 mg. After eight weeks there was remarkable improvement in the induration and pigmentation of the lesions.https://jcdr.net/articles/PDF/17549/60892_CE[Ra1]_F[SK]_PF1(PS_KM_OM)_PN(OM).pdfantibioticsinfectionscleroderma
spellingShingle Deena Patil
Madivalara Yallappa Suparna
Shruthi Madhavi Govindarajulu
Tharayil Kunneth Sumathy
Localised Morphea Treated Empirically with Ceftriaxone
Journal of Clinical and Diagnostic Research
antibiotics
infection
scleroderma
title Localised Morphea Treated Empirically with Ceftriaxone
title_full Localised Morphea Treated Empirically with Ceftriaxone
title_fullStr Localised Morphea Treated Empirically with Ceftriaxone
title_full_unstemmed Localised Morphea Treated Empirically with Ceftriaxone
title_short Localised Morphea Treated Empirically with Ceftriaxone
title_sort localised morphea treated empirically with ceftriaxone
topic antibiotics
infection
scleroderma
url https://jcdr.net/articles/PDF/17549/60892_CE[Ra1]_F[SK]_PF1(PS_KM_OM)_PN(OM).pdf
work_keys_str_mv AT deenapatil localisedmorpheatreatedempiricallywithceftriaxone
AT madivalarayallappasuparna localisedmorpheatreatedempiricallywithceftriaxone
AT shruthimadhavigovindarajulu localisedmorpheatreatedempiricallywithceftriaxone
AT tharayilkunnethsumathy localisedmorpheatreatedempiricallywithceftriaxone